WeissLaw LLP Investigates Blackhawk Network Holdings Inc. Acquisition

Posted on Jan 18, 2018

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Blackhawk Network Holdings Inc. (“HAWK” or the “Company”) (NASDAQ: HAWK) in connection with the proposed acquisition of the Company by private equity firms Silver Lake and P2 Capital Partners.  Under the terms of the acquisition agreement, the Company’s shareholders will receive $45.25 in cash for each HAWK share they own....

Read More

WeissLaw LLP Files Class Action Lawsuit Against Time, Inc.

Posted on Jan 8, 2018

WeissLaw LLP announced that a class action was commenced in the United States District Court for the Southern District of New York on behalf of shareholders of Time, Inc. (“Time”) (NYSE: TIME) seeking to pursue remedies under the Securities Exchange Act of 1934 (the “Exchange Act”) in connection with the proposed acquisition of Time by Meredith Corporation (“Meredith”) (NYSE: MDP). On November 26, 2017, Time and Meredith announced that they had...

Read More

WeissLaw LLP Investigates Archrock Partners, L. P. Acquisition

Posted on Jan 5, 2018

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Archrock Partners, L. P. (“APLP” or the “Company”) (NASDAQ: APLP) in connection with the proposed acquisition of the Company by Archrock, Inc. (“AROC”) (NYSE: AROC).  Under the terms of the acquisition agreement, the Company’s shareholders will receive 1.40 shares of AROC for each APLP share they own, representing...

Read More

WeissLaw LLP Investigates Ignyta Inc. Acquisition

Posted on Dec 22, 2017

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Ignyta Inc. (“RXDX” or the “Company”) (NASDAQ: RXDX) in connection with the proposed acquisition of the Company by Swiss drugmaker Roche Holding AG (“Roche”).  Under the terms of the acquisition agreement, the Company’s shareholders will receive $27.00 in cash for each RXDX share they own. WeissLaw is investigating whether...

Read More

WeissLaw LLP: Kindred Healthcare Inc. Merger May Not Be in the Best Interests of KND Shareholders

Posted on Dec 21, 2017

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Kindred Healthcare Inc. (“KND” or the “Company”) (NYSE: KND) in connection with the proposed acquisition of the Company by Humana Inc. (“HUM”) (NYSE: HUM) and two private equity firms.  Under the terms of the acquisition agreement, shareholders of KND will be entitled to receive $9.00 in cash for each KND share they own....

Read More